Your search returned 64 studies. (Get alerts for new studies):
- Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell Non-Hodgkin's Lymphoma
Conditions: Lymphoma
2 Locations available
- Iodine I 131 Tositumomab and Fludarabine Phosphate in Treating Older Patients Who Are Undergoing an Autologous or Syngeneic Stem Cell Transplant for R
Conditions: Mucosa-Associated Lymphoid Tissue Lymphoma - Monocytoid B-cell Lymphoma - Recurrent Adult Burkitt's Lymphoma - Recurrent Adult Diffuse Large Cell Lymphoma - Recurrent Adult Diffuse Mixed Cell Lymphoma - Recurrent Adult Diffuse Small Cleaved Cell Lymphoma
1 Location available
- Rituximab and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma
Conditions: Lymphoma
227 Locations available
- Genes in Predicting Outcome of Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab and Combination Chemotherapy
Conditions: Lymphoma
2 Locations available
- Lenalidomide, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large Cell or
Conditions: Lymphoma
3 Locations available
- Bortezomib and Vorinostat in Treating Patients With Recurrent Mantle Cell Lymphoma or Recurrent and/or Refractory Diffuse Large B-Cell Lymphoma
Conditions: Lymphoma
7 Locations available
- Fusion Protein Cytokine Therapy After Rituximab in Treating Patients With B-Cell Non-Hodgkin Lymphoma
Conditions: Anaplastic Large Cell Lymphoma - Cutaneous B-cell Non-Hodgkin Lymphoma - Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue - Intraocular Lymphoma - Nodal Marginal Zone B-cell Lymphoma - Recurrent Adult Diffuse Small Cleaved Cel
1 Location available
- Oblimersen Sodium and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage I, Stage II, Stage III, or Stage IV Diffuse Large B-Cel
Conditions: Contiguous Stage II Adult Diffuse Large Cell Lymphoma - Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma - Stage I Adult Diffuse Large Cell Lymphoma - Stage III Adult Diffuse Large Cell Lymphoma - Stage IV Adult Diffuse Large Cell Lymphoma
2 Locations available
- Early Response Assessment in Diffuse Large B-Cell Lymphoma (DLCL) Patients by 18-fluoro-2-deoxyglycose Positron Emission Tomography (FDG-PET)
Conditions: Diffuse Large B-cell Lymphoma
1 Location available
- Lenalidomide With or Without Rituximab After Standard Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma
Conditions: Lymphoma
4 Locations available
- Phase III Study of RAD001 Adjuvant Therapy in Poor Risk Patients With Diffuse Large B-Cell Lymphoma (DLBCL) of RAD001 Versus Matching Placebo After Pa
Conditions: Diffuse Large B-cell Lymphoma
42 Locations available
- R-ICE and High-Dose Cyclophosphamide With PET/CT for Diffuse Large B-Cell Non-Hodgkin's Lymphoma
Conditions: Non-Hodgkin's Lymphoma
1 Location available
- Rituximab, Ifosfamide, Carboplatin, and Etoposide (RICE) Followed by Gallium Nitrate, Rituximab and Dexamethasone (GARD) for Relapsed or Refractory Di
Conditions: Diffuse Large B-cell Lymphoma
1 Location available
- Rituximab in Treating Patients Undergoing Donor Peripheral Blood Stem Cell Transplant for Relapsed or Refractory B-Cell Lymphoma
Conditions: Childhood Diffuse Large Cell Lymphoma - Childhood Immunoblastic Large Cell Lymphoma - Cutaneous B-cell Non-Hodgkin Lymphoma - Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue - Intraocular Lymphoma - Nodal Marginal Zone B-cell
1 Location available
- A Study to Evaluate the Safety and Efficacy of Dasatinib (Sprycel) in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
Conditions: Diffuse Large B-cell Lymphoma
1 Location available
- Study to Assess the Effectiveness of RCHOP With or Without VELCADE in Previously Untreated Non-Germinal Center B-Cell-like Diffuse Large B-Cell Lympho
Conditions: Non-Germinal B-Cell-like (GCB) Diffuse Large B-cell Lymphoma (DLBCL)
68 Locations available
- Immune Response After Stem Cell Transplant in HIV-Positive Patients With Hematologic Cancer
Conditions: Accelerated Phase Chronic Myelogenous Leukemia - Adult Acute Lymphoblastic Leukemia in Remission - Adult Acute Myeloid Leukemia in Remission - Adult Nasal Type Extranodal NK/T-cell Lymphoma - AIDS-related Diffuse Large Cell Lymphoma - AIDS-related Diffuse
1 Location available
- Vorinostat, Rituximab, and Combination Chemotherapy In Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large B-Cell Ly
Conditions: Lymphoma
37 Locations available
- Epigenetic Modulation in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
Conditions: Diffuse Large B-cell Lymphoma
1 Location available
- Bortezomib and Vorinostat as Maintenance Therapy After Autologous Stem Cell Transplant for Non-Hodgkin Lymphoma
Conditions: Anaplastic Large Cell Lymphoma - Contiguous Stage II Adult Diffuse Large Cell Lymphoma - Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma - Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma - Contiguous Stage II Grade 1 Follicular Lymphom
1 Location available
- Detection and Quant of Differences in Hodgkin Lymphoma and Diffuse Large B-cell Lymphoma Using Positron Emission Tomography/Computed Tomography (PET/C
Conditions: Lymphoma
1 Location available
- Phase I/II Trial of R-CHOP + Azacytidine in Diffuse Large B Cell Lymphoma
Conditions: Diffuse Large B Cell Lymphoma
1 Location available
- Autologous Peripheral Blood Stem Cell Transplant Followed by Donor Bone Marrow Transplant in Treating Patients With High-Risk Hodgkin Lymphoma, Non-Ho
Conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma - Anaplastic Large Cell Lymphoma - Angioimmunoblastic T-cell Lymphoma - B-cell Chronic Lymphocytic Leukemia - Burkitt Lymphoma - Childhood Diffuse Large Cell Lymphoma - Childhood Immunoblastic Large Cell Lymp
2 Locations available
- Ofatumumab Versus Rituximab Salvage Chemoimmunotherapy Followed by Autologous Stem Cell Transplant in Relapsed or Refractory Diffuse Large B Cell Lymp
Conditions: Lymphoma, Large-Cell, Diffuse
6 Locations available
- Genetically Engineered Lymphocyte Therapy in Treating Patients With B-Cell Leukemia or Lymphoma That is Resistant or Refractory to Chemotherapy
Conditions: Hematopoietic/Lymphoid Cancer - Adult Acute Lymphoblastic Leukemia in Remission - B-cell Adult Acute Lymphoblastic Leukemia - B-cell Chronic Lymphocytic Leukemia - Prolymphocytic Leukemia - Recurrent Adult Diffuse Large Cell Lymphoma - Recurrent Grade 1 F
1 Location available
- Phase II Trial of Alemtuzumab (Campath) and Dose-Adjusted EPOCH-Rituximab (DA-EPOCH-R) in Relapsed or Refractory Diffuse Large B-Cell and Hodgkin Lymp
Conditions: Hodgkin Lymphoma - Diffuse Large B-Cell Lymphoma
1 Location available
- Patients With Relapsed or Refractory Diffuse Large B Cell Non Hodgkin Lymphomas
Conditions: Non-Hodgkin Lymphomas
2 Locations available
- A Phase 1-2 Study of CAT-8015 in Adult Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia
Conditions: Chronic Lymphocytic Leukemia (CLL) - Diffuse Large B-Cell Lymphoma (DLBCL) - Non-Hodgkin's Lymphoma (NHL) - Follicular Lymphoma (FL) - Mantle Cell Lymphoma (MCL)
1 Location available
- Phase II Study of Dose-Adjusted EPOCH-Rituximab in Adults With Untreated Burkitt Lymphoma and c-MYC+ Diffuse Large B-Cell Lymphoma
Conditions: Burkitt Lymphoma - Diffuse Large B-cell Lymphoma, c-MYC Positive
5 Locations available
- Rituximab, Combination Chemotherapy, Filgrastim (G-CSF), and Plerixafor in Treating Patients With Non-Hodgkin Lymphoma Undergoing Mobilization of Auto
Conditions: Adult Non-Hodgkin Lymphoma - Adult Grade III Lymphomatoid Granulomatosis - Contiguous Stage II Adult Burkitt Lymphoma - Contiguous Stage II Adult Diffuse Large Cell Lymphoma - Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma - Contiguous Stage II Adu
1 Location available
- First in Human Study to Determine the Safety, Tolerability and Preliminary Efficacy of an Anti-CXCR4 Antibody in Subjects With Acute Myelogenous Leuke
Conditions: Acute Myelogenous Leukemia - Diffuse Large B-Cell Leukemia - Chronic Lymphocytic Leukemia - Follicular Lymphoma
6 Locations available
- Study of 5-azacitidine in Combination With Vorinostat in Patients With Relapsed or Refractory Diffuse Large b Cell Lymphoma (DLBCL)
Conditions: Lymphoma
1 Location available
- Observational Study of Diffuse Large B Cell Primary Breast Lymphomas Treated With RCHOP +/- XRT
Conditions: Lymphoma - Non-Hodgkin's Lymphoma
1 Location available
- Bendamustine Hydrochloride, Rituximab, Etoposide, and Carboplatin in Treating Patients With Relapsed or Refractory Lymphoid Malignancies and Select Un
Conditions: Adult Grade III Lymphomatoid Granulomatosis - Adult Nasal Type Extranodal NK/T-cell Lymphoma - Anaplastic Large Cell Lymphoma - Angioimmunoblastic T-cell Lymphoma - Chronic Lymphocytic Leukemia - Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma - Con
1 Location available
- Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myelom
Conditions: Multiple Myeloma - Diffuse Large B-Cell Lymphoma - Glioblastoma Multiforme - Hepatocellular Carcinoma - Non-Small Cell Lung Cancer - Gastrointestinal Neuroendocrine Tumors of Non-Pancreatic Origin - Hormone Receptor-Positive Breast Cancer
8 Locations available
- Btk Inhibitor in Recurrent B Cell Lymphoma
Conditions: Diffuse Large B-Cell Lymphoma - Activated B-Cell Lymphoma
1 Location available
- Tandem Auto-Allo Transplant for Lymphoma
Conditions: Diffuse, Large B-Cell, Lymphoma - Lymphoma, Low-Grade - T-Cell Lymphoma - Mantle-Cell Lymphoma - Hodgkin's Lymphoma - Chronic Lymphocytic Leukemia - Lymphoma, Small Lymphocytic
2 Locations available
- Reduced Radiation in Patients With Diffuse Large B-cell Lymphoma
Conditions: Diffuse Large B-cell Lymphoma
2 Locations available
- Vorinostat and Combination Chemotherapy With Rituximab in Treating Patients With Previously Untreated HIV-Related Diffuse Large B-Cell Non-Hodgkin Lym
Conditions: Lymphoma - Nonneoplastic Condition
13 Locations available
- Study of Lenalidomide to Evaluate Safety and Effectiveness in Patients With Diffuse Large B Cell Lymphoma
Conditions: Diffuse Large B-cell Lymphoma
3 Locations available
- Bendamustine + Rituximab in Older Patients With Previously Untreated Diffuse Large B-cell Lymphoma
Conditions: Diffuse Large B-Cell Lymphoma - Lymphoma, Diffuse Large-Cell - Diffuse Large-Cell Lymphoma - Lymphoma
7 Locations available
- Vaccine Therapy With or Without Cryosurgery in Treating Patients With Residual, Relapsed, or Refractory B-Cell Non-Hodgkin Lymphoma
Conditions: Cutaneous B-cell Non-Hodgkin Lymphoma - Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue - Intraocular Lymphoma - Nodal Marginal Zone B-cell Lymphoma - Recurrent Adult Diffuse Large Cell Lymphoma - Recurrent Adult Diffuse Mixe
1 Location available
- Study of Lenalidomide in Combination With RICE With Lenalidomide Maintenance Post-Auto Transplant for DLBCL
Conditions: Diffuse Large B-cell Lymphoma.
1 Location available
- Panobinostat With Rituximab for Relapsed/Refractory Diffuse Large B Cell Lymphoma
Conditions: Diffuse Large B Cell Lymphoma
3 Locations available
- Imexon for Relapsed Follicular and Aggressive Lymphomas
Conditions: Follicular Lymphoma - Diffuse Large B Cell Lymphoma - Mantle Cell Lymphoma - Burkitt's Lymphoma
1 Location available
- Genetically Engineered Lymphocyte Therapy After Peripheral Blood Stem Cell Transplant in Treating Patients With High-Risk, Intermediate-Grade, B-cell
Conditions: Recurrent Adult Diffuse Large Cell Lymphoma - Recurrent Adult Diffuse Mixed Cell Lymphoma - Recurrent Adult Diffuse Small Cleaved Cell Lymphoma - Recurrent Grade 3 Follicular Lymphoma - Recurrent Mantle Cell Lymphoma
1 Location available
- Comparison of Pixantrone + Rituximab With Gemcitabine + Rituximab in Patients With Aggressive B-cell Non-Hodgkin Lymphoma or Follicular Grade 3 Lympho
Conditions: Diffuse Large B-cell Lymphoma - de Novo DLBCL - DLBCL Transformed From Indolent Lymphoma - Follicular Grade 3 Lymphoma
123 Locations available
- Everolimus, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Untreated Diffuse Large B-Cell Lymphoma
Conditions: Lymphoma
1 Location available
- PET-Directed Therapy in Treating Patients With Limited-Stage Diffuse Large B-Cell Lymphoma
Conditions: Lymphoma
221 Locations available
- TLR8 Agonist VTX-2337 in Combo With Local Radiation in Low-Grade B-cell Lymphomas
Conditions: Lymphoma, Non-Hodgkin - Cutaneous Lymphoma - Large B Cell Diffuse Lymphoma - Mantle Cell Lymphoma - Marginal Zone B-Cell Lymphoma - Peripheral T-cell Lymphoma, Large Cell - Waldenstrom Macroglobulinemia
1 Location available
- Ofatumumab and Bortezomib in Subjects With Relapsed CD20+ NHL
Conditions: Recurrent Adult Diffuse Large Cell Lymphoma - Recurrent Grade 1 Follicular Lymphoma - Recurrent Grade 2 Follicular Lymphoma - Recurrent Grade 3 Follicular Lymphoma - Recurrent Mantle Cell Lymphoma
1 Location available
- MLN8237 in Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma Treated With Rituximab & Vincristine
Conditions: Diffuse Large B-Cell Lymphoma - Transformed Follicular Lymphoma - Mantle Cell Lymphoma - Burkitt's Lymphoma
1 Location available
- Study of AEB071 (a Protein Kinase C Inhibitor) in Patients With CD79-mutant Diffuse Large B-Cell Lymphoma
Conditions: Diffuse Large B-Cell Lymphoma
1 Location available
- A Study of RO5072759 (GA101) in Combination With CHOP Chemotherapy in Patients With Previously Untreated Advanced Diffuse Large B-Cell Lymphoma (GATHE
Conditions: Lymphoma, B-Cell
15 Locations available
- Ruxolitinib Phosphate (Oral JAK Inhibitor INCB18424) in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell or Peripheral T-Cell Non-Ho
Conditions: Peripheral T-cell Lymphoma - Recurrent Adult Diffuse Large Cell Lymphoma - Recurrent Adult T-cell Leukemia/Lymphoma
1 Location available
- High-Dose Y-90-Ibritumomab Tiuxetan Added to Reduced-Intensity Allogeneic Stem Cell Transplant Regimen for Relapsed or Refractory Aggressive B-Cell Ly
Conditions: Post-transplant Lymphoproliferative Disorder - Recurrent Adult Burkitt Lymphoma - Recurrent Adult Diffuse Large Cell Lymphoma - Recurrent Adult Diffuse Mixed Cell Lymphoma - Recurrent Adult Grade III Lymphomatoid Granulomatosis - Recurrent Adult Immunobla
1 Location available
- A Phase 2, Multicenter, Randomized, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
Conditions: Diffuse Large B-Cell Lymphoma (DLBCL)
5 Locations available
- A Phase 1/2 Study of the Oral ALK/EGFR Inhibitor AP26113
Conditions: Advanced Malignancies - Carcinoma, Non-Small-Cell Lung - Anaplastic Large Cell Lymphoma - Diffuse Large Cell Lymphoma - Inflammatory Myofibroblastic Tumors
6 Locations available
- Communication Skills Intervention to Promote Transition Into Survivorship
Conditions: Hodgkin's Lymphoma - Diffuse Large B-cell Lymphoma
2 Locations available
- Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile Neutropenia
Conditions: Adult Acute Lymphoblastic Leukemia - Adult Acute Myeloid Leukemia - Adult Burkitt Lymphoma - Adult Diffuse Large Cell Lymphoma - Adult Diffuse Mixed Cell Lymphoma - Adult Diffuse Small Cleaved Cell Lymphoma - Adult Hodgkin Lymphoma - Adult Immunoblastic L
1 Location available
- Study of Zevalin Versus Observation in Patients at Least 60 Yrs Old With Newly Diagnosed Diffuse Large B-cell Lymphoma in PET-negative Complete Remiss
Conditions: Diffuse Large B-cell Lymphoma - Follicle Center Lymphoma
1 Location available
- Study to Learn if Two Doses of a Test Drug (Fostamatinib) Helps People With Large B-Cell Lymphoma,a Type of Blood Cancer
Conditions: Diffuse Large B-Cell Lymphoma
5 Locations available
- Rituxan/Bendamustine/PCI-32765 in Relapsed DLBCL, MCL, or Indolent Non-Hodgkin's Lymphoma
Conditions: Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue - Nodal Marginal Zone B-cell Lymphoma - Recurrent Adult Diffuse Large Cell Lymphoma - Recurrent Grade 1 Follicular Lymphoma - Recurrent Grade 2 Follicular Lymphoma - Recurrent G
1 Location available
- CD19-specific Donor T Cells for B Cell Malignancies After Allogeneic Transplant
Conditions: Recurrent Adult Acute Lymphoblastic Leukemia - Recurrent Adult Diffuse Large Cell Lymphoma - Recurrent Grade 1 Follicular Lymphoma - Recurrent Grade 2 Follicular Lymphoma - Recurrent Mantle Cell Lymphoma - Recurrent Marginal Zone Lymphoma - Recurrent Smal
1 Location available
|